Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $2.36 million. The enterprise value is -$570,523.
Important Dates
The last earnings date was Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 1.81 million shares outstanding. The number of shares has increased by 1,827.04% in one year.
| Current Share Class | 1.81M |
| Shares Outstanding | 1.81M |
| Shares Change (YoY) | +1,827.04% |
| Shares Change (QoQ) | +13.51% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 5.79% |
| Float | 1.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.92 |
| Quick Ratio | 2.68 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5,051.32 |
Financial Efficiency
Return on equity (ROE) is -126.20% and return on invested capital (ROIC) is -77.40%.
| Return on Equity (ROE) | -126.20% |
| Return on Assets (ROA) | -65.84% |
| Return on Invested Capital (ROIC) | -77.40% |
| Return on Capital Employed (ROCE) | -186.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$978,666 |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.64% in the last 52 weeks. The beta is 0.60, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -62.64% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 2.16 |
| Relative Strength Index (RSI) | 35.86 |
| Average Volume (20 Days) | 72,746 |
Short Selling Information
The latest short interest is 44,129, so 2.43% of the outstanding shares have been sold short.
| Short Interest | 44,129 |
| Short Previous Month | 36,391 |
| Short % of Shares Out | 2.43% |
| Short % of Float | 3.47% |
| Short Ratio (days to cover) | 0.25 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.98M |
| Pretax Income | -6.85M |
| Net Income | -6.85M |
| EBITDA | -6.91M |
| EBIT | -6.98M |
| Earnings Per Share (EPS) | -$6.78 |
Full Income StatementBalance Sheet
The company has $3.08 million in cash and $153,372 in debt, giving a net cash position of $2.93 million or $1.61 per share.
| Cash & Cash Equivalents | 3.08M |
| Total Debt | 153,372 |
| Net Cash | 2.93M |
| Net Cash Per Share | $1.61 |
| Equity (Book Value) | 3.69M |
| Book Value Per Share | 2.25 |
| Working Capital | 2.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.05 million and capital expenditures -$1,125, giving a free cash flow of -$6.05 million.
| Operating Cash Flow | -6.05M |
| Capital Expenditures | -1,125 |
| Free Cash Flow | -6.05M |
| FCF Per Share | -$3.33 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
